外科的治療が有効であったビスフォスフォネート関連下顎骨壊死の1例

A successful case of bisphosphonate-related osteonecrosis of the mandible treated surgically 6 months after terminating bisphosphonate treatment is reported. A 54-year-old woman was referred to our department by her dentist because of diffuse swelling of the left lower gingiva. She noticed swelling...

Full description

Saved in:
Bibliographic Details
Published in日本口腔外科学会雑誌 Vol. 55; no. 7; pp. 354 - 358
Main Authors 米本, 和弘, 浅香, 雄一郎, 山下, 知巳, 牧田, 浩樹, 加藤, 恵三, 柴田, 敏之
Format Journal Article
LanguageJapanese
Published 社団法人 日本口腔外科学会 20.07.2009
Subjects
Online AccessGet full text
ISSN0021-5163
2186-1579
DOI10.5794/jjoms.55.354

Cover

Abstract A successful case of bisphosphonate-related osteonecrosis of the mandible treated surgically 6 months after terminating bisphosphonate treatment is reported. A 54-year-old woman was referred to our department by her dentist because of diffuse swelling of the left lower gingiva. She noticed swelling of the left molar edentulous region of the mandible, covered with a partial denture, and visited her dentist 4 months before the first visit to our department. Conservative therapy was administered, but symptoms did not improve. Thereafter, she was referred to our department because of an abscess. Her past medical history indicated that she had undergone surgical treatment for breast cancer and was receiving bisphosphonate(zoledronic acid)and hormonal preparations for the treatment of bone metastasis. Physical examination revealed sensory disturbance of the left mental region and abscess formation at the left molar region of the mandible. One month later, the bone of the lesion was exposed.Her past medical history and present illness strongly suggested bisphosphonate-related osteonecrosis of the mandible. Therefore, bisphosphonate administration was terminated, and conservative therapy with antibiotics and local irrigation was carried out. After 6 months of conservative therapy, surgical treatment and hyperbaric oxygen therapy were carried out, because radiographic examination suggested that a removable sequestrum had formed. Histopathological findings indicated a sequestrum, and the postoperative course was uneventful.
AbstractList A successful case of bisphosphonate-related osteonecrosis of the mandible treated surgically 6 months after terminating bisphosphonate treatment is reported. A 54-year-old woman was referred to our department by her dentist because of diffuse swelling of the left lower gingiva. She noticed swelling of the left molar edentulous region of the mandible, covered with a partial denture, and visited her dentist 4 months before the first visit to our department. Conservative therapy was administered, but symptoms did not improve. Thereafter, she was referred to our department because of an abscess. Her past medical history indicated that she had undergone surgical treatment for breast cancer and was receiving bisphosphonate(zoledronic acid)and hormonal preparations for the treatment of bone metastasis. Physical examination revealed sensory disturbance of the left mental region and abscess formation at the left molar region of the mandible. One month later, the bone of the lesion was exposed.Her past medical history and present illness strongly suggested bisphosphonate-related osteonecrosis of the mandible. Therefore, bisphosphonate administration was terminated, and conservative therapy with antibiotics and local irrigation was carried out. After 6 months of conservative therapy, surgical treatment and hyperbaric oxygen therapy were carried out, because radiographic examination suggested that a removable sequestrum had formed. Histopathological findings indicated a sequestrum, and the postoperative course was uneventful.
Author 山下, 知巳
加藤, 恵三
牧田, 浩樹
米本, 和弘
浅香, 雄一郎
柴田, 敏之
Author_xml – sequence: 1
  fullname: 米本, 和弘
  organization: 岐阜大学大学院医学系研究科口腔病態学分野
– sequence: 1
  fullname: 浅香, 雄一郎
  organization: 岐阜大学大学院医学系研究科口腔病態学分野
– sequence: 1
  fullname: 山下, 知巳
  organization: 岐阜大学大学院医学系研究科口腔病態学分野
– sequence: 1
  fullname: 牧田, 浩樹
  organization: 岐阜大学大学院医学系研究科口腔病態学分野
– sequence: 1
  fullname: 加藤, 恵三
  organization: 岐阜大学大学院医学系研究科口腔病態学分野
– sequence: 1
  fullname: 柴田, 敏之
  organization: 岐阜大学大学院医学系研究科口腔病態学分野
BookMark eNpFkEtLw0AAhBepYK29-TdS95HNZk8ixRcUvOjVsE13taG1kvTizTQetFVBxIIiiFaoCnrwZKn4Z7YP8i-MD_Qy8w0Dc5hpkNqp7UgAZhHMUcbNOc-rVYMcpTlCzQmQxsi2DJQ0KZCGECODIotMgWwQlIsQUptxRqw02Bzet8fds_HVwei1P75s6PB4dH00bPZ02NVhEjs6vNHRuW70dHShG4__EJ3o6F1Hh3H7Lt7vDN5a8e1p_PQw7DRHz30dvqDBR2sGTCpRCWT21zNgY2lxPb9iFNaWV_MLBcPDmGOjRBi0SYkjV7iMKxNJVyhmEmiaLseQIiikSMBmJcWppbCyJFVFVGQWlkpxkgHzP7teUBdb0tn1y1Xh7znCr5fdinS-z3EoddiXJA_9Ne628B1PkE-xKoIW
ContentType Journal Article
Copyright 2009 社団法人 日本口腔外科学会
Copyright_xml – notice: 2009 社団法人 日本口腔外科学会
DOI 10.5794/jjoms.55.354
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2186-1579
EndPage 358
ExternalDocumentID article_jjoms_55_7_55_354_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
F5P
JSF
KQ8
RJT
ID FETCH-LOGICAL-j2292-d37083d91cac79f41ecaf743044c920510aea92087df956f2f6e5fb1b762eff93
ISSN 0021-5163
IngestDate Wed Sep 03 06:12:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 7
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2292-d37083d91cac79f41ecaf743044c920510aea92087df956f2f6e5fb1b762eff93
OpenAccessLink https://www.jstage.jst.go.jp/article/jjoms/55/7/55_354/_article/-char/ja
PageCount 5
ParticipantIDs jstage_primary_article_jjoms_55_7_55_354_article_char_ja
PublicationCentury 2000
PublicationDate 2009/07/20
PublicationDateYYYYMMDD 2009-07-20
PublicationDate_xml – month: 07
  year: 2009
  text: 2009/07/20
  day: 20
PublicationDecade 2000
PublicationTitle 日本口腔外科学会雑誌
PublicationTitleAlternate 日口外誌
PublicationYear 2009
Publisher 社団法人 日本口腔外科学会
Publisher_xml – name: 社団法人 日本口腔外科学会
References 5) Fisher, J.E., Rogers, M.J., et al.: Alendronate machanism of action: geranylgeranil, an intermediate in the mevalotine pathway, prevents inhibition of osteoclast formation, bone reserption and kinase activation in vitro. Proc Natl Acad Sci USA 96: 133-138 1999.
15) Marx, R.E., Cillo, J.E. Jr., et al.: Oral bisphosphonateinduced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65: 2397-2410 2007.
8) Halasy-Nagy, J.M., Rodan, G.A., et al.: Inhibition of bone resorption by alendronate and risedronete dose not require osteoclast apotosis. Bone 29: 553-559 2001.
4) 竹山禎章, 篠田 壽:各種ビスホスホネートの薬理作用と薬物動態. Clin Calcium 13: 115-121 2003.
9) Assael, L.A.: A time for prospective on bisphosphonates. J Oral Maxillofac Surg 64: 877-879 2006.
7) Benford, H.L., McGowan, N.W.A., et al.: Visualization of bisphosphonate-induced caspase-3 activity in appotoic osteoclasts in vitro. Bone 28: 465-473 2001.
14) 島原政司, 上山吉哉, 他:ビスフォスフォネート投与と関連性があると考えられた顎骨骨髄炎ならびに顎骨壊死に関する調査:日口外誌 53: 594-602 2007.
12) Migliorati, C.A., Casiglia, J., et al.: Managing the care of patients with bisphosphonate-associated osteonecrosis. JADA 136: 1658-1668 2005.
2) Magopoulos, C., Karakinaris, G., et al.: Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 28: 158-163 2007.
3) Kuehn, B.M.: Report of adverse events from bone drugs prompt caution. JAMA 295: 2833-2836 2006.
10) Wood, J., Bonejean, K., et al.: Novel antiangiogenetic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302: 1055-1061 2002.
11) Roelofs, A.J., Thompson, K., et al.: Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12: 6222s-6230s 2006.
6) Hughes, D.E., Wright, K.R., et al.: Bisphosphonates promotes appotosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10: 1478-1487 1995.
13) Marx, R.E.: Pamidronate(Aredia)and zoledronate (Zometa)induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61: 1115- 1117 2003.
1)American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the Jaws. J Oral Maxillofac Surg 65: 369-376 2007.
References_xml – reference: 6) Hughes, D.E., Wright, K.R., et al.: Bisphosphonates promotes appotosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10: 1478-1487 1995.
– reference: 3) Kuehn, B.M.: Report of adverse events from bone drugs prompt caution. JAMA 295: 2833-2836 2006.
– reference: 7) Benford, H.L., McGowan, N.W.A., et al.: Visualization of bisphosphonate-induced caspase-3 activity in appotoic osteoclasts in vitro. Bone 28: 465-473 2001.
– reference: 11) Roelofs, A.J., Thompson, K., et al.: Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12: 6222s-6230s 2006.
– reference: 9) Assael, L.A.: A time for prospective on bisphosphonates. J Oral Maxillofac Surg 64: 877-879 2006.
– reference: 2) Magopoulos, C., Karakinaris, G., et al.: Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 28: 158-163 2007.
– reference: 14) 島原政司, 上山吉哉, 他:ビスフォスフォネート投与と関連性があると考えられた顎骨骨髄炎ならびに顎骨壊死に関する調査:日口外誌 53: 594-602 2007.
– reference: 5) Fisher, J.E., Rogers, M.J., et al.: Alendronate machanism of action: geranylgeranil, an intermediate in the mevalotine pathway, prevents inhibition of osteoclast formation, bone reserption and kinase activation in vitro. Proc Natl Acad Sci USA 96: 133-138 1999.
– reference: 10) Wood, J., Bonejean, K., et al.: Novel antiangiogenetic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302: 1055-1061 2002.
– reference: 8) Halasy-Nagy, J.M., Rodan, G.A., et al.: Inhibition of bone resorption by alendronate and risedronete dose not require osteoclast apotosis. Bone 29: 553-559 2001.
– reference: 15) Marx, R.E., Cillo, J.E. Jr., et al.: Oral bisphosphonateinduced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65: 2397-2410 2007.
– reference: 1)American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the Jaws. J Oral Maxillofac Surg 65: 369-376 2007.
– reference: 13) Marx, R.E.: Pamidronate(Aredia)and zoledronate (Zometa)induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61: 1115- 1117 2003.
– reference: 4) 竹山禎章, 篠田 壽:各種ビスホスホネートの薬理作用と薬物動態. Clin Calcium 13: 115-121 2003.
– reference: 12) Migliorati, C.A., Casiglia, J., et al.: Managing the care of patients with bisphosphonate-associated osteonecrosis. JADA 136: 1658-1668 2005.
SSID ssib005879736
ssib058493840
ssj0001742264
ssib000940266
Score 1.7744071
Snippet A successful case of bisphosphonate-related osteonecrosis of the mandible treated surgically 6 months after terminating bisphosphonate treatment is reported. A...
SourceID jstage
SourceType Publisher
StartPage 354
SubjectTerms ゾレドロン酸水和物
ビスフォスフォネート
外科的治療
顎骨壊死
Title 外科的治療が有効であったビスフォスフォネート関連下顎骨壊死の1例
URI https://www.jstage.jst.go.jp/article/jjoms/55/7/55_354/_article/-char/ja
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本口腔外科学会雑誌, 2009/07/20, Vol.55(7), pp.354-358
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1Na9RQMJR68SKKit_04DtJavJeXt57x2SbUhQFoYWeXJNscliwirYXT27Xg7YqiFhQBNEKVUEPniwV_0z6wf4LZybZ3VQK1iIsYXbem3nzkWRmwvuwrIsmwVOM3dwWRvu2p6VjG19BzSNEDgErbuU0q_LadX9qxrsyK2dHRm_VZi0tzCfj6YM915UcxKuAA7_iKtl_8OyAKSAABv_CFTwM1335mEWSBR4zPosUCxQzLgImYNpjkc9CzsKQMIZpziIBaSPTDWwyDaYNkuuAhaZqAg5Vn37nQFSAmSRAMFNieJ8KMLLCBOZvTfCbqICw0cdoFhlUIeAIaIcG9ViomQ4RE4A8EQEBCzSpLFBs0CKYIAVLUSOXyCIgq2fcpC1YR1ZqBw1Se5KGgTEkM95edpTIPfCJZwNtilKG1KRRFD34vIxEoctCMRwB7lvkYDiZWxIHPewPrpE4Mirlo3eoP_FHz5XKO2QO0C0aEkoayB3ahwgVugcVhGYQRdQFAy-jWxVqGTplfxoeXeKjQUOz68sPLjazuTN4VskkZFdUKCSz-agsOhfwcP8El_6XkesxlLu2dKuwlBEODzazXVkeC9SPq-X2y9X7Q9WCpCi3Da_yLVFu3f9nKAdmHoby9p3b98elHB8Q7docvXr0mtStKWVT4QX6NvstuHix2YYK6hBXiiZyXL1RK0CM5_BaQSO1MkoM_kN2bkR_NyT6aqto5Xk5b6w0Q7maBsW9XBcWMto21Hf9uaGUrk4ftY5UdeZYUMp3zBppx8etm1sfV3bWXuy8ebT9fWPn9WLRebr99snW0nrRWSs68He16Lwrui-LxfWi-6pY_DwEus-K7s-i-7i38qH3cHXzx3Lv_fPel09bq0vbXzeKzjd389fyCWtmMppuTNnVASt2m3PD7ZZQUIG1jJvGqTK552ZpjG9ox_NSwzFcx1kMgFat3Eg_57mfyTxxE8igsjw34qQ1OndnLjtljTl54sfACjcW9tKWTlIv5UkaiySRMnH5aUuX5mjeLXfRae7bdWcOTnrWOjx8cM5Zo_P3FrLzUETMJxfoPvgNrpvk7Q
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%A4%96%E7%A7%91%E7%9A%84%E6%B2%BB%E7%99%82%E3%81%8C%E6%9C%89%E5%8A%B9%E3%81%A7%E3%81%82%E3%81%A3%E3%81%9F%E3%83%93%E3%82%B9%E3%83%95%E3%82%A9%E3%82%B9%E3%83%95%E3%82%A9%E3%83%8D%E3%83%BC%E3%83%88%E9%96%A2%E9%80%A3%E4%B8%8B%E9%A1%8E%E9%AA%A8%E5%A3%8A%E6%AD%BB%E3%81%AE1%E4%BE%8B&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%8F%A3%E8%85%94%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E7%B1%B3%E6%9C%AC%2C+%E5%92%8C%E5%BC%98&rft.au=%E6%B5%85%E9%A6%99%2C+%E9%9B%84%E4%B8%80%E9%83%8E&rft.au=%E5%B1%B1%E4%B8%8B%2C+%E7%9F%A5%E5%B7%B3&rft.au=%E7%89%A7%E7%94%B0%2C+%E6%B5%A9%E6%A8%B9&rft.date=2009-07-20&rft.pub=%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%8F%A3%E8%85%94%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5163&rft.eissn=2186-1579&rft.volume=55&rft.issue=7&rft.spage=354&rft.epage=358&rft_id=info:doi/10.5794%2Fjjoms.55.354&rft.externalDocID=article_jjoms_55_7_55_354_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5163&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5163&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5163&client=summon